Cantor Fitzgerald initiated coverage on Stratasys with a new price target
$SSYS
Computer peripheral equipment
Technology
Cantor Fitzgerald initiated coverage of Stratasys with a rating of Overweight and set a new price target of $24.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/13/2024 | $24.00 | Overweight | Cantor Fitzgerald |
| 1/4/2023 | $15.00 | Hold → Buy | Needham |
| 11/8/2022 | Underperform → Mkt Perform | William Blair | |
| 8/17/2022 | $24.00 | Outperform | Credit Suisse |
| 5/17/2022 | $25.00 → $23.00 | Underweight → Neutral | JP Morgan |
| 2/24/2022 | $30.00 | Hold → Buy | Cross Research |
| 11/4/2021 | Neutral → Underweight | JP Morgan | |
| 11/4/2021 | Overweight → Neutral | JP Morgan |
-Promising results obtained from the pre-clinical study with CollPlant's commercial sized rhCollagen-based regenerative breast implants, demonstrating significant implant vascularization and rapid ingrowth of native tissue -Innovative breast implant technology designed to address a $3.0 billion market opportunity -Cash and cash equivalents balance as of September 30, 2024 was $15.4 million -Conference call to be held today at 10:00 a.m. U.S. EDT – REHOVOT, Israel, Nov. 27, 2024 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ:CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue regeneration
Raises 2024 Margins and Profitability Outlook Revenue of $140.0 million, compared to $162.1 million in third quarter 2023 Eighth consecutive quarter of year-over-year growth in recurring consumables revenue reflects continued strong printer utilization Improved GAAP gross margin by 430bps to 44.8% and non-GAAP gross margin by 130bps to 49.6% compared to third quarter 2023 GAAP net loss of $26.6 million, or $0.37 per diluted share; non-GAAP net income resumes achieving profitability with $0.4 million, or $0.01 per diluted share $4.5 million of cash used in operations; year-to-date operating cash flow remains positive Adjusted EBITDA of $5.1 million Restructuring cost sa
Stratasys Ltd. (NASDAQ:SSYS) will release financial results for the third quarter ended September 30, 2024, on Wednesday, November 13, 2024. The Company plans to hold the conference call to discuss its third quarter 2024 financial results on Wednesday, November 13, 2024, at 8:30 a.m. (ET). The investor conference call will be available via live webcast on the Stratasys Web site at investors.stratasys.com; or directly at the following web address: https://event.choruscall.com/mediaframe/webcast.html?webcastid=xEC56y1o To participate by telephone, the U.S. toll-free number is 877-407-0619 and the international dial-in is +1-412-902-1012. Investors are advised to dial into the call at least
TrueDent-D™ resin is now available in major European markets that require CE marking, with strong customer interest already building Stratasys (NASDAQ:SSYS) has declared that its TrueDent-D™ resin is available for sale in Europe as a CE Mark Class I medical device. This milestone enables the sale of its TrueDent™ monolithic multi-shade digital denture solution in European countries that require CE marking. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250114856677/en/Stratasys Launches TrueDent™ in Europe (Photo: Business Wire) Following its successful debut in the United States in 2023, TrueDent is now set to deliver a scala
Stratasys highlights achievements in environmental, social, and governance initiatives, cementing its position as a supplier of choice for sustainable AM-enabled production solutions. Stratasys Ltd. (NASDAQ:SSYS) today announced the publication of its third Mindful Manufacturing™ ESG (Environment, Social, and Governance) and Sustainability Report. Prepared in accordance with the Global Reporting Initiative (GRI) and referencing SASB (Sustainability Accounting Standards Board) standards, the report underscores Stratasys' commitment to ESG excellence and enterprise risk management through best-in-class corporate governance, a people-first approach, meaningful social impact, and robust envir
Stratasys F370® 3D Printer and GrabCAD Print Software Enable ArcelorMittal Maizières Research's Adoption of 3D Printing for Applications Previously Unattainable with Traditional Manufacturing ArcelorMittal, a leading steel manufacturer in Europe, has expanded its use of 3D printing by adopting the F370® 3D printer within its research centre based in Maizières-lès-Metz, transforming the tooling and prototyping aspects of its manufacturing processes, Stratasys (NASDAQ:SSYS) announced today. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241216639528/en/A 3D-printed protection cap, taking the place of an original aluminum part th
8-A12B/A - STRATASYS LTD. (0001517396) (Filer)
6-K - STRATASYS LTD. (0001517396) (Filer)
6-K - STRATASYS LTD. (0001517396) (Filer)
SC 13G/A - STRATASYS LTD. (0001517396) (Subject)
SC 13G/A - STRATASYS LTD. (0001517396) (Subject)
SC 13G/A - STRATASYS LTD. (0001517396) (Subject)
Stratasys highlights achievements in environmental, social, and governance initiatives, cementing its position as a supplier of choice for sustainable AM-enabled production solutions. Stratasys Ltd. (NASDAQ:SSYS) today announced the publication of its third Mindful Manufacturing™ ESG (Environment, Social, and Governance) and Sustainability Report. Prepared in accordance with the Global Reporting Initiative (GRI) and referencing SASB (Sustainability Accounting Standards Board) standards, the report underscores Stratasys' commitment to ESG excellence and enterprise risk management through best-in-class corporate governance, a people-first approach, meaningful social impact, and robust envir
Medical facilities and device manufacturers previously limited by constraints can now create patient-specific models to enhance surgical preparation, elevate patient outcomes, and fast-track innovation Stratasys Ltd. (NASDAQ:SSYS) today announced the launch of its J5™ Digital Anatomy™ 3D printer, the latest innovation designed to address the growing demand for cost-effective, high-fidelity anatomical models. This Stratasys innovation is designed to enable hospitals, medical device manufacturers and research institutions to enhance patient outcomes, streamline operations and bring products to market faster. This press release features multimedia. View the full release here: https://www.bu
Appointment of Amir Kleiner will strengthen the connection between the Customer Success organization and the Operations and Supply Chain divisions Stratasys Ltd. (NASDAQ:SSYS) today announced the appointment of Amir Kleiner as Chief Operating Officer. The 12-year Stratasys veteran will lead the company's Global Operations, MIS, and Quality team, while continuing to manage the Customer Success team. The appointment is set to strengthen the connection between the Customer Success organization and the Operations and Supply Chain divisions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240408469494/en/Amir Kleiner, Chief Operatin
Cantor Fitzgerald initiated coverage of Stratasys with a rating of Overweight and set a new price target of $24.00
Needham upgraded Stratasys from Hold to Buy and set a new price target of $15.00
William Blair upgraded Stratasys from Underperform to Mkt Perform